Novartis, a global innovative medicines company, is expanding its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over the next five years, designed to increase manufacturing capacity and enable 100% of the company’s key medicines to be produced end-to-end in the U.S. As part of this flagship hub in North Carolina, Novartis will:...